Evidence map›Paper›PMID 40670868›Full record

ArticleBiochemical genetics2026

VHL Suppresses Angiogenesis Through HIF-1a-Mediated Ang/Tie2/AMPK/VEGF Signaling Pathway in Tie-2 Expressed Macrophages (TEMs).

Min-Cheng Zou, Yu-Hao Yang, Yun-Peng Mao, Ya Liu, Hui-Bing Gao, Wen-Dong Liu, Jia Liu, Fu-Yong Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Biochemical genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Min-Cheng Zou *Department of Orthopedics, Children's Hospital of Soochow University, Suzhou, China.
Yu-Hao Yang *Department of Orthopedics, Children's Hospital of Soochow University, Suzhou, China.
Yun-Peng MaoDepartment of Orthopedics, Children's Hospital of Soochow University, Suzhou, China.
Ya LiuDepartment of Orthopedics, Children's Hospital of Soochow University, Suzhou, China.
Hui-Bing GaoYangliu Central Health Center, Xintai, Shandong, China.
Wen-Dong LiuDepartment of Orthopedics, Children's Hospital of Soochow University, Suzhou, China.
Jia LiuDepartment of Obstetrics and Gynecology, Suzhou Municipal Hospital, Suzhou, China. 2271634769@qq.com.
Fu-Yong ZhangDepartment of Orthopedics, Children's Hospital of Soochow University, Suzhou, China. zhangfuyong@suda.edu.cn.

Funding

Suzhou Municipal Hospital Slyyhl202303
6 · The paper itself

Abstract

The cartilage of the growth plate is crucial for the longitudinal growth of long bones but is highly susceptible to injury due to its avascular nature. Growth plate injuries frequently result in the formation of a bone bridge, leading to limb length discrepancies and angular deformities. Angiogenesis is a critical factor in the repair process, as new blood vessels deliver oxygen, nutrients, and cellular components essential for bone regeneration. Tie2-expressing macrophages (TEMs) play a pivotal role in promoting angiogenesis in tumors and remodeled tissues; however, their precise function and regulatory mechanisms in epiphyseal plate injury repair remain unclear. This study investigates the role of the VHL/HIF-1α/Tie2/AMPK/Autophagy axis in TEM-mediated angiogenesis. Our findings identify VHL as a key regulator of TEM-driven angiogenesis, where VHL overexpression suppresses, and VHL silencing enhances the pro-angiogenic potential of TEMs. Mechanistically, VHL downregulates HIF-1α, reducing Tie2 surface expression, which in turn modulates AMPK-mediated autophagy. This pathway influences VEGF secretion, thereby promoting endothelial cell proliferation, migration, survival, and tube formation. These findings uncover a novel regulatory mechanism governing TEM-mediated angiogenesis and offer insights into potential therapeutic strategies to enhance vascularization, improve growth plate injury repair, and mitigate long-term orthopedic complications.

Indexed as

AMP-Activated Protein KinasesHypoxia-Inducible Factor 1, alpha SubunitMacrophagesNeovascularization, PathologicNeovascularization, PhysiologicReceptor, TIE-2Vascular Endothelial Growth Factor AVon Hippel-Lindau Tumor Suppressor ProteinAngiogenesisAngiopoietin-1AnimalsHumansMiceSignal TransductionAMP-Activated Protein KinasesAngiopoietin-1Hif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitReceptor, TIE-2Tek protein, mouseVascular Endothelial Growth Factor AVHL protein, mouseVon Hippel-Lindau Tumor Suppressor ProteinAutophagyClinical applicationsEpiphyseal plate injuryMacrophagesVHL

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.